A detailed history of Townsquare Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Townsquare Capital LLC holds 378,773 shares of NVO stock, worth $39.2 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
378,773
Previous 389,980 2.87%
Holding current value
$39.2 Million
Previous $55.7 Million 18.98%
% of portfolio
0.55%
Previous 0.77%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $1.33 Million - $1.63 Million
-11,207 Reduced 2.87%
378,773 $45.1 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $5.68 Million - $6.81 Million
46,324 Added 13.48%
389,980 $55.7 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $148,672 - $197,899
1,456 Added 0.43%
343,656 $44.1 Million
Q4 2023

Feb 15, 2024

SELL
$87.78 - $105.45 $1.54 Million - $1.85 Million
-17,552 Reduced 4.88%
342,200 $35.4 Million
Q3 2023

Nov 15, 2023

BUY
$90.94 - $199.54 $21.4 Million - $46.9 Million
235,277 Added 189.02%
359,752 $32.7 Million
Q2 2023

Nov 13, 2023

BUY
$155.98 - $172.65 $3.01 Million - $3.33 Million
19,305 Added 18.36%
124,475 $20.1 Million
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $2.14 Million - $2.57 Million
-16,170 Reduced 13.33%
105,170 $16.7 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $261,502 - $345,091
2,550 Added 2.15%
121,340 $16.4 Million
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $286,697 - $351,842
3,009 Added 2.6%
118,790 $11.8 Million
Q2 2022

Aug 08, 2022

BUY
$103.24 - $121.81 $240,033 - $283,208
2,325 Added 2.05%
115,781 $12.9 Million
Q1 2022

Apr 28, 2022

BUY
$93.1 - $112.54 $889,384 - $1.08 Million
9,553 Added 9.19%
113,456 $12.6 Million
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $1.2 Million - $1.47 Million
12,523 Added 13.7%
103,903 $11.6 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $103,245 - $130,396
1,223 Added 1.36%
91,380 $8.77 Million
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $953,938 - $1.2 Million
14,099 Added 18.54%
90,157 $7.67 Million
Q1 2021

May 17, 2021

BUY
$67.06 - $75.82 $33,194 - $37,530
495 Added 0.66%
76,058 $5.13 Million
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $502,367 - $580,289
7,863 Added 11.61%
75,563 $5.28 Million
Q3 2020

Dec 01, 2020

BUY
$63.69 - $70.22 $646,453 - $712,733
10,150 Added 17.64%
67,700 $4.68 Million
Q2 2020

Aug 17, 2020

BUY
$58.54 - $67.94 $40,743 - $47,286
696 Added 1.22%
57,550 $3.75 Million
Q1 2020

May 18, 2020

BUY
$49.46 - $64.78 $703,617 - $921,560
14,226 Added 33.37%
56,854 $3.61 Million
Q4 2019

May 18, 2020

BUY
$49.86 - $58.26 $365,772 - $427,395
7,336 Added 20.79%
42,628 $2.47 Million
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $368,435 - $414,082
7,750 Added 28.14%
35,292 $1.99 Million
Q2 2019

Aug 15, 2019

SELL
$46.79 - $52.47 $2.66 Million - $2.98 Million
-56,842 Reduced 67.36%
27,542 $1.34 Million
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $1.72 Million - $1.95 Million
37,141 Added 78.62%
84,384 $4.41 Million
Q4 2018

Feb 13, 2019

BUY
$41.54 - $47.25 $1.96 Million - $2.23 Million
47,243 New
47,243 $2.31 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Townsquare Capital LLC Portfolio

Follow Townsquare Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.